FR2457872B1 - - Google Patents

Info

Publication number
FR2457872B1
FR2457872B1 FR8011680A FR8011680A FR2457872B1 FR 2457872 B1 FR2457872 B1 FR 2457872B1 FR 8011680 A FR8011680 A FR 8011680A FR 8011680 A FR8011680 A FR 8011680A FR 2457872 B1 FR2457872 B1 FR 2457872B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8011680A
Other languages
French (fr)
Other versions
FR2457872A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
Original Assignee
Tokyo Tanabe Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13367224&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2457872(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tokyo Tanabe Co Ltd filed Critical Tokyo Tanabe Co Ltd
Publication of FR2457872A1 publication Critical patent/FR2457872A1/fr
Application granted granted Critical
Publication of FR2457872B1 publication Critical patent/FR2457872B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42Respiratory system, e.g. lungs, bronchi or lung cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fats And Perfumes (AREA)
  • Steroid Compounds (AREA)
FR8011680A 1979-06-02 1980-05-27 Procede de production de matieres tensio-actives, nouveaux produits ainsi obtenus et compositions pharmaceutiques pour le traitement de maladie de la membrane hyaline contenant ces matieres tensio-actives Granted FR2457872A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6821179A JPS55160721A (en) 1979-06-02 1979-06-02 Pulmonary surfactant ta-546, its preparation, and remedy for pulmonary hyaline membrane syndrome comprising it as active constituent

Publications (2)

Publication Number Publication Date
FR2457872A1 FR2457872A1 (fr) 1980-12-26
FR2457872B1 true FR2457872B1 (enExample) 1984-09-21

Family

ID=13367224

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8011680A Granted FR2457872A1 (fr) 1979-06-02 1980-05-27 Procede de production de matieres tensio-actives, nouveaux produits ainsi obtenus et compositions pharmaceutiques pour le traitement de maladie de la membrane hyaline contenant ces matieres tensio-actives

Country Status (8)

Country Link
US (1) US4338301A (enExample)
JP (1) JPS55160721A (enExample)
AU (1) AU520543B2 (enExample)
CA (1) CA1161754A (enExample)
DE (1) DE3021006C2 (enExample)
FR (1) FR2457872A1 (enExample)
GB (1) GB2050832B (enExample)
MX (1) MX9203482A (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5795920A (en) * 1980-12-04 1982-06-15 Teijin Ltd Remedy for respiratory disease
DE3228629A1 (de) * 1982-07-31 1984-02-02 Reifenrath, Rainer Richard Otto, Dr., 3104 Unterlüß Pharmazeutisches erzeugnis zur behandlung der atemwege und verfahren zu seiner herstellung
DE3229179C2 (de) * 1982-08-05 1986-04-17 A. Nattermann & Cie GmbH, 5000 Köln Lungensurfactant
JPS59164724A (ja) * 1983-03-10 1984-09-17 Tokyo Tanabe Co Ltd サ−フアクタント及びそれを含有する呼吸窮迫症候群治療剤
DD225841C2 (de) * 1983-12-08 1986-04-16 Dresden Arzneimittel Verfahren zur herstellung eines mittels zur behandlung von erkrankungen, die mit veraenderungen des pulmonalen surfactant-systems einhergehen
CS938384A1 (en) * 1983-12-08 1990-08-14 Lachmann Burkhardt Pharmaceutical agent for breathlesness therapy and method of its production
FR2559669B1 (fr) * 1984-02-20 1986-05-09 Nabavi Seyfeddine Lipoproteine haute densite cholesterol synthetique
IL71051A (en) * 1984-02-23 1988-02-29 Yeda Res & Dev Compositions containing active lipids for the treatment of cystic fibrosis
US5013720A (en) * 1986-05-06 1991-05-07 Abbott Laboratories SAP-6-Val proteins and methods
JPH01501282A (ja) * 1986-12-08 1989-05-11 ホイツトセツト,ジエフリー エイ. 肺胞疎水性界面活性物質関連タンパク質
IT1203873B (it) * 1987-04-08 1989-02-23 Chiesi Farma Spa Composizioni farmaceutiche che lo surfattante polmonare naturale, contengono. metodo di preparazione e
US4861756A (en) * 1988-03-08 1989-08-29 Merrell Dow Pharmaceuticals Inc. Synthetic pulmonary surfactant
AU3073789A (en) * 1988-03-31 1989-10-05 Abbott Laboratories Drug delivery using pulmonary surfactant to facilitate absorption
DE3921954A1 (de) * 1989-07-04 1991-01-17 Thomae Gmbh Dr K Niedrig-viskose, hochkonzentrierte surfactant-suspension
CO5021218A1 (es) * 1994-12-29 2001-03-27 Ct Nac De Sanidad Agropecuaria Surfactante pulmonar natural porcino
US6129934A (en) * 1995-06-07 2000-10-10 Ony, Inc. Modification of animal lung surfactant for treating respiratory disease due to lung surfactant deficiency or dysfunction
US6172203B1 (en) * 1996-02-07 2001-01-09 Alfredo Adolfo Hager Method for extracting and purifying pulmonary surfactant
EP0904295B1 (en) * 1996-05-15 2005-08-10 ALTANA Pharma AG Process for separating and analyzing hydrophobic proteins using thin layer chromatography
US6855342B2 (en) * 2000-06-30 2005-02-15 Medicis Pharmaceutical Corporation Compositions and methods for high sorption of skin materials and delivery of sulfur
US6514489B1 (en) 2000-06-30 2003-02-04 Medicis Pharmaceutical Corp. Sulfur containing dermatological compositions and methods for reducing malodors in dermatological compositions
US20050025817A1 (en) * 2003-07-03 2005-02-03 Bhatia Kuljit S. Delivery system for topical medications
US7479289B2 (en) * 2004-07-02 2009-01-20 Medicis Pharmaceutical Corporation Stable cleanser compositions containing sulfur
US7582312B2 (en) * 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
US7464012B2 (en) * 2004-12-10 2008-12-09 L'air Liquide, Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude Et L'exploitation Des Procedes Georges Claude Simplified process simulator
GB0426010D0 (en) * 2004-11-26 2004-12-29 Britannia Pharmaceuticals Ltd Improvements in or relating to organic materials
US11219843B2 (en) * 2019-07-08 2022-01-11 Nik Paya Karen Pharmed Extraction of animal-derived pulmonary surfactants

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3594476A (en) * 1969-05-12 1971-07-20 Massachusetts Inst Technology Submicron aqueous aerosols containing lecithin

Also Published As

Publication number Publication date
AU5867880A (en) 1981-12-10
FR2457872A1 (fr) 1980-12-26
DE3021006C2 (de) 1983-03-17
MX9203482A (es) 1992-08-01
JPS55160721A (en) 1980-12-13
GB2050832A (en) 1981-01-14
DE3021006A1 (de) 1981-01-08
CA1161754A (en) 1984-02-07
GB2050832B (en) 1983-08-03
US4338301A (en) 1982-07-06
AU520543B2 (en) 1982-02-04
JPS619925B2 (enExample) 1986-03-27

Similar Documents

Publication Publication Date Title
FR2450447B3 (enExample)
FR2457872B1 (enExample)
BR8002583A (enExample)
BR8006808A (enExample)
FR2449931B3 (enExample)
FR2446009B1 (enExample)
FR2449434B2 (enExample)
FR2450240B1 (enExample)
FR2446907B1 (enExample)
FR2449318B1 (enExample)
FR2446002B1 (enExample)
FR2447286B1 (enExample)
FR2449681B1 (enExample)
FR2447889B1 (enExample)
FR2449450B1 (enExample)
FR2450175B1 (enExample)
FR2447514B1 (enExample)
FR2449978B1 (enExample)
AU78386S (enExample)
AU78270S (enExample)
AU78389S (enExample)
AU78271S (enExample)
AU78385S (enExample)
AU78390S (enExample)
AU78391S (enExample)

Legal Events

Date Code Title Description
CP Supplementary protection certificate (spc) filed

Free format text: PRODUCT NAME: LIPIDES DE POUMONS DE BOVINS; DIPALMITOATE DE PHOSPHATIDYLCHOLINE; ACIDE PALMITIQUE; TRIPALMITINE; NAT. REGISTRATION NO/DATE: NL 17649 19940516; FIRST REGISTRATION: DE - 18348.00.00 19891025

Spc suppl protection certif: 94C0008

Filing date: 19940624

CP Supplementary protection certificate (spc) filed

Free format text: 94C0008, 940624

CR Request for supplementary protection certificate laid open to the public (eec regulation of 18 june 1992)

Free format text: 94C0008, 940624

CP Supplementary protection certificate (spc) filed
CY Supplementary certificate of protection granted (eec regulation of 18 june 1992)

Free format text: 94C0008, 940624, EXPIRES:20041025

CP Supplementary protection certificate (spc) filed
TP Transmission of property
CD Change of name or company name
TP Transmission of property